1007 related articles for article (PubMed ID: 12207783)
21. T-cell/histiocyte-rich large B-cell lymphoma displays a heterogeneity similar to diffuse large B-cell lymphoma: a clinicopathologic, immunohistochemical, and molecular study of 30 cases.
Wang J; Sun NC; Chen YY; Weiss LM
Appl Immunohistochem Mol Morphol; 2005 Jun; 13(2):109-15. PubMed ID: 15894921
[TBL] [Abstract][Full Text] [Related]
22. Large B-cell lymphoma rich in T-cells and simulating Hodgkin's disease.
Chittal SM; Brousset P; Voigt JJ; Delsol G
Histopathology; 1991 Sep; 19(3):211-20. PubMed ID: 1655614
[TBL] [Abstract][Full Text] [Related]
23.
Schuhmacher B; Bein J; Rausch T; Benes V; Tousseyn T; Vornanen M; Ponzoni M; Thurner L; Gascoyne R; Steidl C; Küppers R; Hansmann ML; Hartmann S
Haematologica; 2019 Feb; 104(2):330-337. PubMed ID: 30213827
[TBL] [Abstract][Full Text] [Related]
24. Differential diagnosis between classic Hodgkin's lymphoma, T-cell-rich B-cell lymphoma, and paragranuloma by paraffin immunohistochemistry.
Rüdiger T; Ott G; Ott MM; Müller-Deubert SM; Müller-Hermelink HK
Am J Surg Pathol; 1998 Oct; 22(10):1184-91. PubMed ID: 9777980
[TBL] [Abstract][Full Text] [Related]
25. High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltratein Hodgkin's lymphoma.
van den Berg A; Visser L; Poppema S
Am J Pathol; 1999 Jun; 154(6):1685-91. PubMed ID: 10362793
[TBL] [Abstract][Full Text] [Related]
26. [Nodular lymphocyte-predominant Hodgkin's lymphoma and differential diagnoses].
Hartmann S; Cogliatti S; Hansmann ML
Pathologe; 2013 May; 34(3):233-43. PubMed ID: 23494280
[TBL] [Abstract][Full Text] [Related]
27. T-cell/histiocyte-rich large B-cell lymphoma associated with a near-tetraploid karyotype and complex genetic abnormalities.
de Leval L; Harris NL; Lampertz S; Herens C
APMIS; 2006 Jun; 114(6):474-8. PubMed ID: 16856972
[TBL] [Abstract][Full Text] [Related]
28. [Classical Hodgkin's lymphoma: biology and grey zones].
Gaulard P; Brousse N
Ann Pathol; 2004 Sep; 24(4):330-48. PubMed ID: 15567950
[TBL] [Abstract][Full Text] [Related]
29. Leukocyte-specific phosphoprotein-1 and PU.1: two useful markers for distinguishing T-cell-rich B-cell lymphoma from lymphocyte-predominant Hodgkin's disease.
Marafioti T; Mancini C; Ascani S; Sabattini E; Zinzani PL; Pozzobon M; Pulford K; Falini B; Jaffe ES; Müller-Hermelink HK; Mason DY; Pileri SA
Haematologica; 2004 Aug; 89(8):957-64. PubMed ID: 15339679
[TBL] [Abstract][Full Text] [Related]
30. Bone marrow involvement in T-cell-rich B-cell lymphoma.
Skinnider BF; Connors JM; Gascoyne RD
Am J Clin Pathol; 1997 Nov; 108(5):570-8. PubMed ID: 9353097
[TBL] [Abstract][Full Text] [Related]
31. T-cell/histiocyte-rich B cell lymphoma mimicking Hodgkin's lymphoma.
Majhi U; Shirley S; Murhekar KM
Indian J Cancer; 2010; 47(1):70-2. PubMed ID: 20071794
[No Abstract] [Full Text] [Related]
32. T-bet, a T cell-associated transcription factor, is expressed in Hodgkin's lymphoma.
Dorfman DM; Hwang ES; Shahsafaei A; Glimcher LH
Hum Pathol; 2005 Jan; 36(1):10-5. PubMed ID: 15712176
[TBL] [Abstract][Full Text] [Related]
33. Primary cutaneous lymphoproliferative disorders with dual lineage rearrangement.
Kazakov DV; Kutzner H; Palmedo G; Boudova L; Michaelis S; Michal M; Vanecek T; Magro CM; Mukensnabl P; Dummer R; Burg G; Kempf W
Am J Dermatopathol; 2006 Oct; 28(5):399-409. PubMed ID: 17012914
[TBL] [Abstract][Full Text] [Related]
34. Lymphocyte-rich classical Hodgkin's lymphoma: distinctive tumor and microenvironment markers.
Nam-Cha SH; Montes-Moreno S; Salcedo MT; Sanjuan J; Garcia JF; Piris MA
Mod Pathol; 2009 Aug; 22(8):1006-15. PubMed ID: 19465900
[TBL] [Abstract][Full Text] [Related]
35. Nodular lymphocyte-predominant Hodgkin's disease associated with large-cell lymphoma: analysis of Ig gene rearrangements by V-J polymerase chain reaction.
Greiner TC; Gascoyne RD; Anderson ME; Kingma DW; Adomat SA; Said J; Jaffe ES
Blood; 1996 Jul; 88(2):657-66. PubMed ID: 8695813
[TBL] [Abstract][Full Text] [Related]
36. Sequential immunohistochemistry: a promising new tool for the pathology laboratory.
van den Brand M; Hoevenaars BM; Sigmans JH; Meijer JW; van Cleef PH; Groenen PJ; Hebeda KM; van Krieken JH
Histopathology; 2014 Nov; 65(5):651-7. PubMed ID: 24766252
[TBL] [Abstract][Full Text] [Related]
37. Sequential development of Hodgkin's disease and CD30+ diffuse large B-cell lymphoma in a patient with MALT-type lymphoma: evidence of different clonal origin of single microdissected Reed-Sternberg cells.
Parrens M; Vergier B; Fitoussi O; Lahet C; Belleannee G; Marit G; Dubus P; de Mascarel A; Delfau-Larue MH; Merlio JP
Am J Surg Pathol; 2002 Dec; 26(12):1634-42. PubMed ID: 12459631
[TBL] [Abstract][Full Text] [Related]
38. T-cell-rich B-cell lymphomas. A clinicopathologic study of 19 cases.
Macon WR; Williams ME; Greer JP; Stein RS; Collins RD; Cousar JB
Am J Surg Pathol; 1992 Apr; 16(4):351-63. PubMed ID: 1373580
[TBL] [Abstract][Full Text] [Related]
39. How to differentiate between T-cell-rich B-cell lymphoma and lymphocyte-predominant Hodgkin's disease. Evidence for the value of MB1 and 4KB5 immunostaining.
Schmidt U; Herbst J; Metz KA; Leder LD
J Pathol; 1996 Jun; 179(2):138-44. PubMed ID: 8758204
[TBL] [Abstract][Full Text] [Related]
40. Composite B-cell and T-cell lymphoma arising 24 years after nodular lymphocyte predominant Hodgkin's disease.
Hancock JC; Wells A; Halling KC; Tilashalski K; Conner MG; Johns C; Listinsky CM
Ann Diagn Pathol; 1999 Feb; 3(1):23-34. PubMed ID: 9990110
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
